• DKSH Holding AG first-half profit after tax rose 9.2% to CHF 105.2 million, while diluted EPS increased to CHF 1.66.
• Net sales fell 0.9% to CHF 5.47 billion, while EBIT declined 4.8% to CHF 158 million.
• Free cash flow climbed to CHF 147.7 million from CHF 121.6 million, leaving net cash/(debt) at CHF -10.8 million at June 30.
• Agreed to buy Biomedic in Vietnam for about CHF 14.3 million and AIC Ingredients in Malaysia for about CHF 95 million, both slated to close in Q3 2026.
• Completed the acquisition of Gale & Cosm on July 9 for a CHF 5 million cash payment, with a 10% earnout over two years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DKSH Holding AG published the original content used to generate this news brief on July 17, 2026, and is solely responsible for the information contained therein.